Items where authors include "Duquenne, L."

Article

Harnden, K., Sidhu, N., Rowbotham, E. et al. (8 more authors) (2025) Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study. The Lancet Rheumatology. ISSN 2665-9913

Siddle, H.J., Wilson, M., Nam, J.L. et al. (5 more authors) (2024) A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care. Rheumatology. keae653. ISSN 1462-0324

Anioke, I. orcid.org/0000-0001-7600-4823, Duquenne, L., Parmar, R. et al. (4 more authors) (2024) Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals. Rheumatology, 63 (6). pp. 1720-1732. ISSN 1462-0324

Di Matteo, A. orcid.org/0000-0003-0867-7051, Mankia, K. orcid.org/0000-0002-7945-6582, Garcia-Montoya, L. et al. (5 more authors) (2024) Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD Open, 10 (2). e003927. ISSN 2056-5933

Garcia-Montoya, L., Kang, J., Duquenne, L. et al. (6 more authors) (2024) Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study. The Lancet Rheumatology, 6 (2). e72-e80. ISSN 2665-9913

Duquenne, L. orcid.org/0000-0001-7631-0986, Hensor, E.M. orcid.org/0000-0002-5245-4755, Wilson, M. et al. (11 more authors) (2023) Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification. Annals of Internal Medicine, 176 (8). pp. 1027-1036. ISSN 0003-4819

Conference or Workshop Item

Sharrack, S., Yu, X., Jayaraman, A. et al. (17 more authors) (2025) POS0067 Elevated serum peptidylarginine deiminase 4 (PAD4) levels in anti-CCP antibody positive at-risk individuals with arthralgia who progress to rheumatoid arthritis. In: EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain.

Yu, X., Hester, S., Harnden, K. et al. (10 more authors) (2023) POS0442 Endocitrullination Of RA Autoantigens Is More Abundant Than C-Terminal Citrullination In The Gingival Crevicular Fluid Of Anti-CCP Positive At-Risk Individuals With Periodontal Disease But No Synovitis. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

Siddle, H.J. orcid.org/0000-0002-6015-332X, Wilson, M., Nam, J.L. et al. (5 more authors) (2024) OA03 Developing a multivariable prediction model to identify anti-CCP positive individuals among those with non-specific musculoskeletal symptoms in primary care. In: Rheumatology. British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool, UK. Oxford University Press , i2-i2.